Navigation Links
Nu Skin Enterprises to Announce First Quarter 2008 Results
Date:4/9/2008

PROVO, Utah, April 9 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced it will release first-quarter financial results prior to the market opening on Thursday, May 1, 2008.

Truman Hunt, president and chief executive officer, will host a conference call with the investment community later that same day beginning at 11 a.m. (ET). During the call, participants can expect to hear management review past results and discuss upcoming plans and business initiatives.

The webcast of the conference call, including the financial information to be presented, will be available on the investor section of the company's Web site at http://www.nuskinenterprises.com. A replay of the webcast will be available from the same location through Friday, May 16, 2008.

The Company

Nu Skin Enterprises, Inc. is a global direct selling company operating in more than 45 markets throughout Asia, the Americas and Europe. The company markets premium-quality personal care products under the Nu Skin(R) brand, science-based nutritional supplements under the Pharmanex(R) brand, and technology products and services under the Big Planet(R) brand. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS."


'/>"/>
SOURCE Nu Skin Enterprises, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. CJPS Enterprises to Expand Efforts of 21st Century Jobs Fund Life Sciences Pipeline
2. Nu Skin Enterprises to Present at Bank of America 2008 Consumer Conference
3. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
4. Nu Skin Enterprises Announces Increase in Quarterly Dividend
5. CJPS Enterprises Spins Off New Company for Intellectual Property Marketing
6. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China
7. BME (BioMedical Enterprises, Inc.) Announces U.S. Launch of the OSSArc(TM) Anatomic Residual Compression Implant
8. Dr. Andrew K. Palmer Joins BMEs (BioMedical Enterprises, Inc.) Board of Directors
9. Medsphere & Keane Join Forces to Provide Healthcare Enterprises With Integrated Electronic Health Record & Revenue Cycle Management Systems
10. Duane Reade Holdings, Inc. Announces Resignation of Chief Marketing Officer
11. Best Practices, LLC Announces New Benchmarking Study - How World-Class Companies Proactively Manage Competitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...mbudsman that they should respect the desire of pa...eiving emergency// contraception. A woman had alre...ked by the pharmacists while she was buying the Le...estions asked were with regard to the woman’s sexu...
... to be launched in the Indian city of Hyderabad, e...ology hub. // This will be a biotech incubation ce...acility which will come up to international standa...iotech firms, including several multinationals, ha...
...in the tissue environment of the breast that occur.... This study has found a place in the February iss...tages of pregnancy, lactation, and involution dict...f the human breast, resulting in multiplication, d...
...out the cancer causing potential of perfluorooctan...Teflon or non-stick cookware. // The concern was t...ittee for the Environmental Protection Agency said...otential. "The predominant panel view was that th...
Other Medicine News:Health News:Biotechnology Initiatives Planned In Hyderabad 2
(Date:9/3/2008)...atology Research and Education Foundation,s Withi...n Detecting, Treating and Unde...r the first time during its,unprecedented initiati...erican College of Rheumatology Research and Educat...ed from research funded by the Within Our,Reach: F...
(Date:9/3/2008)...l Vascular Disease Awareness Month, CHARLOTTESVIL...euticals,LLC, a clinical-stage drug-development co...of unmet medical needs, announced today that it ha...l trial of its lead drug,candidate trans sodium cr...,on the clinicaltrials.gov Website, is investigati...
(Date:9/3/2008).../- Panacea Pharmaceuticals,Inc. toda...13,737 covering,antibodies against human aspartyl ...ry human cancer biomarker and therapeutic target. ...ith the Massachusetts Institute of,Technology (MIT...his patent,for development of human cancer diagnos...
(Date:9/3/2008)...cuss Phase 3 Plans with FDA, PRINCETON, N.J., Sep...ounced today that it successfully completed two ke...y,s new, innovative low-dose, once-weekly,contrac...nternal product,code AG-200-15. The Phase 2b safet...endpoint of ovulation suppression, cycle control a...
Breaking Medicine Technology:New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 1Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 2Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 3Colonoscopy Remains the Most Effective Screening Option for Colon Cancer 2681 4Using additional biopsy scoring data may help determine prostate cancer prognosis 2676 1Using additional biopsy scoring data may help determine prostate cancer prognosis 2676 2Switching to MA Coverage Unlikely for Current Beneficiaries With MediGap or Medicare Only 2672 1Tobacco Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking 2667 1Tobacco Free Kids Applauds Tyra Banks for Exposing the Ugly Truth About Smoking 2667 2
...tion of rapid, easy-to-use diagnostic tests, many ...rketplace to help clinicians assess dosage appropr...e presence of drugs of abuse. Some of these produc...st kits are suitable for point of care use by medi..., , Therapeutic drug monitoring measures the ...
...causes infectious mononucleosis (IM), is one of th... and most people become infected with EBV sometime... as 95 percent of adults between 35 and 40 years o...ies, including the U.S., infection with EBV most o... causing infectious mononucleosis in 35 percent to...
Other Medicine Technology:Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 2Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 3Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse 4Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 2Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies 3
...demand environments like OB/GYN, ER/Trauma, ICC/CC... delivers precision and control, plus consistent h...FESKIN* SATIN PLUS* Sterile Singles delive...excellent tactile sensitivity. The gloves are powd...
UROLOGY DRAPE. Soft translucent material for excellent shape conformity. Latex finger cot with additional adhesive ring around base. Full-width 50mm adhesive strip for secure fixing, with finger lift
NEAR-SkinTM Incise Drape Aggressive adhesive with no residue High moisture permeability for extended adhesion Low-glare matte finish film Product number identification
...the Penilab IV and the Penilab V have an exception...al studies. Model 1060 is similar to the Model 10...can one be added later. The Penilab V has a Doppl...of the accessories you'll need to get started. La...
Medicine Products: